HSPD1 and ovarian carcinoma: In fact, HSP60 inhibition has been implemented as a therapeutic strategy in various types of cancers including melanoma (Kamm et al., 2019), pancreatic cancer (Zhou et al., 2018), and ovarian cancer (Guo et al., 2019).